Earnings call transcript

Price reaction · full curve

Awaiting price reaction for this filing.

AI summary

Eris Lifesciences has informed the stock exchanges that the transcript of its analyst and investor conference call, held after announcing Q4 and full-year FY25 financial results, has been uploaded to its website. The filing is signed by Milind Talegaonkar, Company Secretary. No specific financial figures, management commentary, or forward-looking guidance are included in this particular filing — only a pointer to where the transcript can be accessed.

Likely market impact

This is a routine disclosure and is unlikely to move the stock on its own. Investors who want deeper insights into management's outlook, margin commentary, or strategy for FY26 should read the actual transcript on the company website.